Home / Stocks / TMO

Thermo Fisher Scientific (TMO, Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued

Thermo Fisher Scientific (TMO, Life Sciences Tools & Services) trades at a blended P/E of 25.8, about 28% above its historical normal valuation, with a forward growth estimate of 9.6% and a PEG of 2.68. Analysts' one-year estimates have been hit 82% of the time.

Blended P/E
25.8
Normal P/E
20.2
PEG
2.68
Fwd growth
9.6%
Div yield
0.3%
RSI (14)
74.5
Overbought

The Street vs SeerForecast

Wall Street's mean price target for TMO is $631.42 across 26 analysts, 0.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from trading above fair value (2026-06-03) to significantly overvalued (2026-08-21).

Price and rating by weekClose moved +24.2 percent from 2026-06-03 to 2026-08-17, with 2 rating changes over 21 recorded weeks.2026-06-03: Trading above fair value, close 473.48 (recalculated)2026-06-10: Trading above fair value, close 481.56 (recalculated)2026-06-14: Trading above fair value, close 468.87 (recalculated)2026-06-16: Trading above fair value, close 472.63 (recalculated)2026-06-21: Trading above fair value, close 464.61 (recalculated)2026-07-02: Trading above fair value, close 523.44 (recalculated)2026-07-06: Trading above fair value, close 517.60 (recalculated)2026-07-09: Trading above fair value, close 524.71 (recalculated)2026-07-12: Trading above fair value, close 527.05 (recalculated)2026-07-13: Trading above fair value, close 528.51 (recalculated)2026-07-14: Trading above fair value, close 534.07 (recalculated)2026-07-20: Trading above fair value, close 526.23 (recalculated)2026-07-22: Trading above fair value, close 526.46 (recalculated)2026-07-25: Trading above fair value, close 568.26 (recalculated)2026-07-27: Trading above fair value, close 559.53 (recalculated)2026-07-31: Trading above fair value, close 574.30 (recalculated)2026-08-03: Trading above fair value, close 574.302026-08-07: Trading above fair value, close 594.00 (recalculated)2026-08-10: Significantly overvalued, close 594.002026-08-14: Significantly overvalued, close 588.29 (recalculated)2026-08-17: Trading above fair value, close 588.294735882026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 20.6+2%Trading above fair value
2026-06-10P/E 19.9-1%Trading above fair value
2026-06-14P/E 19.9-1%Trading above fair value
2026-06-16P/E 19.9-1%Trading above fair value
2026-06-21P/E 19.9-1%Trading above fair value
2026-07-02P/E 21.5+6%Trading above fair value
2026-07-06P/E 21.9+9%Trading above fair value
2026-07-09P/E 21.9+9%Trading above fair value
2026-07-12P/E 22.0+9%Trading above fair value
2026-07-13P/E 22.0+9%Trading above fair value
2026-07-14P/E 22.0+9%Trading above fair value
2026-07-20P/E 22.2+10%Trading above fair value
2026-07-22P/E 22.2+10%Trading above fair value
2026-07-25P/E 23.6+17%Trading above fair value
2026-07-27P/E 23.6+17%Trading above fair value
2026-07-31P/E 23.9+18%Trading above fair value
2026-08-03P/E 23.8+18%Trading above fair value
2026-08-07P/E 23.9+19%Trading above fair value
2026-08-10P/E 24.5+21%Significantly overvalued
2026-08-14P/E 24.6+22%Significantly overvalued
2026-08-17P/E 24.2+20%Trading above fair value
2026-08-21P/E 25.8+28%Significantly overvalued ← now

Frequently asked questions

Is Thermo Fisher Scientific stock overvalued?

At a blended P/E of 25.8 versus its historical normal P/E of 20.2, Thermo Fisher Scientific trades about 28% above its typical valuation, with a PEG of 2.68 on 9.6% forward growth. tickerseer currently rates it significantly overvalued.

What is Thermo Fisher Scientific's fair value and PEG?

Thermo Fisher Scientific trades at a blended P/E of 25.8 against a historical normal P/E of 20.2, a PEG of 2.68, and a forward growth estimate of 9.6%.

Has tickerseer's rating of Thermo Fisher Scientific changed?

tickerseer's rating moved from trading above fair value (2026-06-03) to significantly overvalued (2026-08-21).

What is the analyst price target for Thermo Fisher Scientific?

The mean Wall Street price target for Thermo Fisher Scientific is $631.42 across 26 analysts, 0.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.